Business & FinanceHealth

Major Bayer shareholder Harris backs CEO’s focus on internal restructuring

07 March 2024, 1:56 pm 1 minute

Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.

Market Impact

The news caused Bayer’s shares to significantly narrow losses. The group’s stock closed down 0.9% following the comments after having fallen as much as 6.3% earlier in the session.

Article Tags

Topics of Interest: Business & FinanceHealth

Type: Reuters Best

Sectors: Business & FinancePharmaceuticals & Healthcare

Regions: Europe

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story

Share this article

Work Email Address *

Country *

I'd like to receive communications about Reuters resources, events, products, or services.

(Please note you can manage and update your preferences at any time.) By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.

By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field

Work Email Address *

Country *

More of Reuters Best

JPMorgan CEO Jamie Dimon to visit Africa in growth push

Major Bayer shareholder Harris backs CEO’s focus on internal restructuring

Market Impact

More of Reuters Best

JPMorgan CEO Jamie Dimon to visit Africa in growth push

Ryanair raises summer fare outlook as ‘ugly scenario’ avoided

India flags cricket rights concerns with Disney-Reliance $8.5 bln merger

Custody giant State Street expands crypto services in new partnership